ArticleCase reports in ophthalmological medicine2026
Genetic Insights Into Retinitis Pigmentosa: A De Novo
Article in Case reports in ophthalmological medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Genetic Insights Into Retinitis Pigmentosa: A De NovoCase reports in ophthalmological medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Retinitis pigmentosa (RP) is a genetically heterogeneous disease characterized by progressive vision loss and blindness, primarily due to the degeneration of cone photoreceptor cells. The classic symptoms include a decline in visual acuity and retinal atrophy. In this study, whole-exome sequencing (WES) was performed on a 40-year-old man from a nonconsanguineous Iranian-Azeri Turkish family, who was diagnosed with vision loss and blindness at age 40. DNA was extracted from the proband, his healthy brother, sister, and mother to conduct segregation analysis. WES analysis revealed a hemizygous mutation in a single nucleotide (NC_000023.11)(NM_001034853.2) c.194G>T, located in exon 3 of the
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.